Nuvectis Pharma (NVCT) Interest & Investment Income (2022 - 2026)
Nuvectis Pharma (NVCT) posted Interest & Investment Income of $177,000 for Q2 2026, down 32.2% from $261,000 a year earlier and down 15.7% from the prior quarter.
Powered by 
Analysis
Nuvectis Pharma (NVCT) Interest & Investment Income (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Nuvectis Pharma was $1.02 million, up 13.1% year-over-year; for FY2025, it was $1.13 million, up 33.6% from FY2024.
- Annual Interest & Investment Income has increased for three consecutive years, with a four-year compound annual growth rate of 310.2% (FY2021 to FY2025).
- In prior years, Nuvectis Pharma's Interest & Investment Income was $847,000 in FY2024 (+33.0%), $637,000 in FY2023 (+327.5%), $149,000 in FY2022 and $4,000 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q2 2023.
- On a year-over-year basis, Interest & Investment Income increased in four of the last eight quarters, with growth averaging 6.5%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2023, with growth of 354.1%; the weakest was Q2 2026, with a decline of 32.2%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $210,000 (Q1 2026), $303,000 (Q4 2025) and $332,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Nuvectis Pharma | 585.15 Mn | 585.15 Mn | - | 177,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 261,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 206,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 244,000.00 |
| Sep 30, 2023 | 277,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 61,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 2,000.00 |
API Access
Nuvectis Pharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();